Gallic Acid: A Potent Metabolite Targeting Shikimate Kinase in .

is a highly multidrug-resistant pathogen resistant to almost all classes of antibiotics; new therapeutic strategies against this infectious agent are urgently needed. Shikimate kinase is an enzyme belonging to the shikimate pathway and has become a potential target for drug development. This work describes the search for Food and Drug Administration (FDA)-approved drugs and natural compounds, including gallic acid, that could be repurposed as selective shikimate kinase inhibitors by integrated computational and experimental approaches.

Impact of Spinal Anesthesia Dosage in Elective Cesarean Section on the Duration of Stay in Post-Anesthesia Care Unit at the Women's Health Hospital, National Guard Health Affairs.

In the field of obstetrics, cesarean sections have now become the most prominent procedure for the delivery of newborns. Cesarean sections may be handled with a variety of different anesthetic approaches, of which most focus seems to be on that of spinal forms, due to their rapid and effective action. Dosages of spinal anesthesia formulations differ depending on multiple variables, such as depth of anesthesia, level of analgesia, and desired duration of effects.

Knowledge and Awareness of Amblyopia Among the Adult Population of the Al-Baha Region, Saudi Arabia.

Background: Amblyopia results from abnormal visual development, leading to reduced vision. Early recognition of the disease can facilitate early treatment and increase the chances of recovering visual acuity. Despite its prevalence and treatable nature, there is a concerning lack of awareness about amblyopia among the general population in Saudi Arabia.

Assessment of Healthcare Professionals' Knowledge and Practices About Radioactive Iodine Preparation in Thyroid Cancer Patients.

Background Radioactive iodine (iodine-131) therapy is widely used for treating thyroid cancer. However, the knowledge and practices of healthcare professionals in preparing patients for radioactive iodine therapy may vary, potentially affecting patient outcomes. Objective This study aimed to evaluate the knowledge and practices of healthcare professionals at King Abdulaziz Medical City (KAMC) in Jeddah, regarding the preparation of patients with thyroid cancer for radioactive iodine therapy.

Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy.

Patient-derived tumor organoids (PDTOs) represent a significant advancement in cancer research and personalized medicine. These organoids, derived from various cancer types, have shown the ability to retain the genetic and molecular characteristics of the original tumors, allowing for the detailed study of tumor biology and drug responses on an individual basis. The success rates of establishing PDTOs vary widely and are influenced by factors such as cancer type, tissue quality, and media composition.